OBJECTIVE: To characterize longitudinal MRI and PET abnormalities in autopsy-confirmed Pick disease (PiD) and determine how patterns of neurodegeneration differ with respect to clinical syndrome. METHODS: Seventeen patients with PiD were identified who had antemortem MRI (8 with behavioral variant frontotemporal dementia [bvFTD-PiD], 6 with nonfluent/agrammatic primary progressive aphasia [naPPA-PiD], 1 with semantic primary progressive aphasia, 1 with unclassified primary progressive aphasia, and 1 with corticobasal syndrome). Thirteen patients had serial MRI for a total of 56 MRIs, 7 had [18F]fluorodeoxyglucose PET, 4 had Pittsburgh compound B (PiB) PET, and 1 patient had [18F]flortaucipir PET. Cross-sectional and longitudinal comparisons of gray matter volume and metabolism were performed between bvFTD-PiD, naPPA-PiD, and controls. Cortical PiB summaries were calculated to determine β-amyloid positivity. RESULTS: The bvFTD-PiD and naPPA-PiD groups showed different foci of volume loss and hypometabolism early in the disease, with bvFTD-PiD involving bilateral prefrontal and anterior temporal cortices and naPPA-PiD involving left inferior frontal gyrus, insula, and orbitofrontal cortex. However, patterns merged over time, with progressive spread into prefrontal and anterior temporal lobe in naPPA-PiD, and eventual involvement of posterior temporal lobe, motor cortex, and parietal lobe in both groups. Rates of frontotemporal atrophy were faster in bvFTD-PiD than naPPA-PiD. One patient was β-amyloid-positive on PET with low Alzheimer neuropathologic changes at autopsy. Flortaucipir PET showed elevated uptake in frontotemporal white matter. CONCLUSION: Patterns of atrophy and hypometabolism differ in PiD according to presenting syndrome, although patterns of neurodegeneration appear to converge over time.
OBJECTIVE: To characterize longitudinal MRI and PET abnormalities in autopsy-confirmed Pick disease (PiD) and determine how patterns of neurodegeneration differ with respect to clinical syndrome. METHODS: Seventeen patients with PiD were identified who had antemortem MRI (8 with behavioral variant frontotemporal dementia [bvFTD-PiD], 6 with nonfluent/agrammatic primary progressive aphasia [naPPA-PiD], 1 with semantic primary progressive aphasia, 1 with unclassified primary progressive aphasia, and 1 with corticobasal syndrome). Thirteen patients had serial MRI for a total of 56 MRIs, 7 had [18F]fluorodeoxyglucose PET, 4 had Pittsburgh compound B (PiB) PET, and 1 patient had [18F]flortaucipir PET. Cross-sectional and longitudinal comparisons of gray matter volume and metabolism were performed between bvFTD-PiD, naPPA-PiD, and controls. Cortical PiB summaries were calculated to determine β-amyloid positivity. RESULTS: The bvFTD-PiD and naPPA-PiD groups showed different foci of volume loss and hypometabolism early in the disease, with bvFTD-PiD involving bilateral prefrontal and anterior temporal cortices and naPPA-PiD involving left inferior frontal gyrus, insula, and orbitofrontal cortex. However, patterns merged over time, with progressive spread into prefrontal and anterior temporal lobe in naPPA-PiD, and eventual involvement of posterior temporal lobe, motor cortex, and parietal lobe in both groups. Rates of frontotemporal atrophy were faster in bvFTD-PiD than naPPA-PiD. One patient was β-amyloid-positive on PET with low Alzheimer neuropathologic changes at autopsy. Flortaucipir PET showed elevated uptake in frontotemporal white matter. CONCLUSION: Patterns of atrophy and hypometabolism differ in PiD according to presenting syndrome, although patterns of neurodegeneration appear to converge over time.
Authors: O Piguet; G M Halliday; W G J Reid; B Casey; R Carman; Y Huang; J H Xuereb; J R Hodges; J J Kril Journal: Neurology Date: 2011-01-18 Impact factor: 9.910
Authors: Katherine P Rankin; Mary Catherine Mayo; William W Seeley; Suzee Lee; Gil Rabinovici; Maria Luisa Gorno-Tempini; Adam L Boxer; Michael W Weiner; John Q Trojanowski; Stephen J DeArmond; Bruce L Miller Journal: J Mol Neurosci Date: 2011-09-01 Impact factor: 3.444
Authors: Katerina A Tetzloff; Joseph R Duffy; Heather M Clark; Rene L Utianski; Edythe A Strand; Mary M Machulda; Hugo Botha; Peter R Martin; Christopher G Schwarz; Matthew L Senjem; Robert I Reid; Jeffrey L Gunter; Anthony J Spychalla; David S Knopman; Ronald C Petersen; Clifford R Jack; Val J Lowe; Keith A Josephs; Jennifer L Whitwell Journal: Brain Date: 2019-08-01 Impact factor: 13.501
Authors: Jennifer L Whitwell; Peter R Martin; Joseph R Duffy; Heather M Clark; Mary M Machulda; Christopher G Schwarz; Stephen D Weigand; Irene Sintini; Matthew L Senjem; Nilufer Ertekin-Taner; Hugo Botha; Rene L Utianski; Jonathan Graff-Radford; David T Jones; Bradley F Boeve; David S Knopman; Ronald C Petersen; Clifford R Jack; Val J Lowe; Keith A Josephs Journal: Neurology Date: 2019-01-11 Impact factor: 9.910
Authors: Renaud La Joie; Nagehan Ayakta; William W Seeley; Ewa Borys; Adam L Boxer; Charles DeCarli; Vincent Doré; Lea T Grinberg; Eric Huang; Ji-Hye Hwang; Milos D Ikonomovic; Clifford Jack; William J Jagust; Lee-Way Jin; William E Klunk; Julia Kofler; Orit H Lesman-Segev; Samuel N Lockhart; Val J Lowe; Colin L Masters; Chester A Mathis; Catriona L McLean; Bruce L Miller; Daniel Mungas; James P O'Neil; John M Olichney; Joseph E Parisi; Ronald C Petersen; Howard J Rosen; Christopher C Rowe; Salvatore Spina; Prashanthi Vemuri; Victor L Villemagne; Melissa E Murray; Gil D Rabinovici Journal: Alzheimers Dement Date: 2018-10-19 Impact factor: 21.566
Authors: Marta Marquié; Marc D Normandin; Charles R Vanderburg; Isabel M Costantino; Elizabeth A Bien; Lisa G Rycyna; William E Klunk; Chester A Mathis; Milos D Ikonomovic; Manik L Debnath; Neil Vasdev; Bradford C Dickerson; Stephen N Gomperts; John H Growdon; Keith A Johnson; Matthew P Frosch; Bradley T Hyman; Teresa Gómez-Isla Journal: Ann Neurol Date: 2015-09-25 Impact factor: 10.422
Authors: Jonathan D Rohrer; Tammaryn Lashley; Jonathan M Schott; Jane E Warren; Simon Mead; Adrian M Isaacs; Jonathan Beck; John Hardy; Rohan de Silva; Elizabeth Warrington; Claire Troakes; Safa Al-Sarraj; Andrew King; Barbara Borroni; Matthew J Clarkson; Sebastien Ourselin; Janice L Holton; Nick C Fox; Tamas Revesz; Martin N Rossor; Jason D Warren Journal: Brain Date: 2011-09 Impact factor: 13.501
Authors: Val J Lowe; Geoffry Curran; Ping Fang; Amanda M Liesinger; Keith A Josephs; Joseph E Parisi; Kejal Kantarci; Bradley F Boeve; Mukesh K Pandey; Tyler Bruinsma; David S Knopman; David T Jones; Leonard Petrucelli; Casey N Cook; Neill R Graff-Radford; Dennis W Dickson; Ronald C Petersen; Clifford R Jack; Melissa E Murray Journal: Acta Neuropathol Commun Date: 2016-06-13 Impact factor: 7.801
Authors: Kejal Kantarci; Val J Lowe; Qin Chen; Scott A Przybelski; Timothy G Lesnick; Christopher G Schwarz; Matthew L Senjem; Jeffrey L Gunter; Clifford R Jack; Jonathan Graff-Radford; David T Jones; David S Knopman; Neill Graff-Radford; Tanis J Ferman; Joseph E Parisi; Dennis W Dickson; Ronald C Petersen; Bradley F Boeve; Melissa E Murray Journal: Neurology Date: 2019-12-20 Impact factor: 11.800
Authors: Lucia A A Giannini; Claire Peterson; Daniel Ohm; Sharon X Xie; Corey T McMillan; Katya Raskovsky; Lauren Massimo; EunRah Suh; Vivianna M Van Deerlin; David A Wolk; John Q Trojanowski; Edward B Lee; Murray Grossman; David J Irwin Journal: Acta Neuropathol Commun Date: 2021-02-23 Impact factor: 7.801
Authors: Sarah E Burke; Jeffrey S Phillips; Christopher A Olm; Claire S Peterson; Phillip A Cook; James C Gee; Edward B Lee; John Q Trojanowski; Lauren Massimo; David J Irwin; Murray Grossman Journal: Neurobiol Aging Date: 2022-02-24 Impact factor: 5.133